Bone morphogenetic protein signaling in prostate cancer cell lines
- 7 October 2003
- journal article
- prospect
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 91 (1) , 151-160
- https://doi.org/10.1002/jcb.10679
Abstract
Prostate cancer is the most commonly diagnosed malignancy in men and is often associated with bone metastases. Prostate cancer bone lesions can be lytic or schlerotic, with the latter predominating. Bone morphogenetic proteins (BMPs) are a family of growth factors, which may play a role in the formation of prostate cancer osteoblastic bone metastases. This study evaluated the effects of BMPs on prostate cancer cell lines. We observed growth inhibitory effects of BMP-2 and -4 on LNCaP, while PC-3 was unaffected. Flow cytometric analysis determined that LNCaP cell growth was arrested in G1 after bone morphogenetic protein-2 treatment. Treatment of LNCaP and PC-3 with BMP-2 and -4 activated downstream signaling pathways involving SMAD-1, up-regulation of p21CIP1/WAF1 and changes in retinoblastoma (Rb) phosphorylation. Interestingly, bone morphogenetic protein-2 treatment stimulated a 2.7-fold increase in osteoprotegerin (OPG), a molecule, which inhibits osteoclastogenesis, production in PC-3.Keywords
This publication has 59 references indexed in Scilit:
- Increased expression of bone morphogenetic protein‐7 in bone metastatic prostate cancerThe Prostate, 2003
- Overexpression of BMP-2 Modulates Morphology, Growth, and Gene Expression in Osteoblastic CellsExperimental Cell Research, 2002
- BMP-7-Induced Cell Cycle Arrest of Anaplastic Thyroid Carcinoma Cells via p21CIP1 and p27KIP1Biochemical and Biophysical Research Communications, 2001
- Cbfa1 Contributes to the Osteoblast-specific Expression of type I collagen GenesJournal of Biological Chemistry, 2001
- Bone morphogenetic protein-6: potential mediator of osteoblastic metastases in prostate cancerProstate Cancer and Prostatic Diseases, 2000
- The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and FunctionJournal of Biological Chemistry, 2000
- Bone Morphogenetic Protein-2 Blocks MDA MB 231 Human Breast Cancer Cell Proliferation by Inhibiting Cyclin-Dependent Kinase-Mediated Retinoblastoma Protein PhosphorylationBiochemical and Biophysical Research Communications, 2000
- Osteoprotegerin Production by Human Osteoblast Lineage Cells Is Stimulated by Vitamin D, Bone Morphogenetic Protein-2, and CytokinesBiochemical and Biophysical Research Communications, 1998
- Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRsOncogene, 1997
- Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cellsBone, 1996